BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30887206)

  • 1. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide Proton Transfer Weighted MR Imaging for Predicting Meningioma Stiffness: A Feasibility Study.
    Yu H; Zhu L; Wang Y; Yue X; Wang W; Sun Z; Jiang S; Chen Y; Wen Z
    J Magn Reson Imaging; 2023 Apr; 57(4):1071-1078. PubMed ID: 35932167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
    Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
    Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma: Correlation with Ki-67 proliferation status.
    Li Y; Lin CY; Qi YF; Wang X; Chen B; Zhou HL; Ren J; Yang JJ; Xiang Y; He YL; Xue HD; Jin ZY
    Magn Reson Imaging; 2021 May; 78():18-24. PubMed ID: 33556484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of apparent diffusion coefficient with Ki-67 proliferation index, progesterone-receptor status and various histopathological parameters, and its utility in predicting the high grade in meningiomas.
    Bozdağ M; Er A; Ekmekçi S
    Acta Radiol; 2021 Mar; 62(3):401-413. PubMed ID: 32397733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
    Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
    AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
    Li L; Chen W; Yan Z; Feng J; Hu S; Liu B; Liu X
    J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide proton transfer imaging for differentiation of benign and atypical meningiomas.
    Joo B; Han K; Choi YS; Lee SK; Ahn SS; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2018 Jan; 28(1):331-339. PubMed ID: 28687916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Diffusional Kurtosis Imaging, Diffusion Tensor Imaging, and Diffusion-Weighted Imaging in Grading and Assessing Cellular Proliferation of Meningiomas.
    Lin L; Bhawana R; Xue Y; Duan Q; Jiang R; Chen H; Chen X; Sun B; Lin H
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1032-1038. PubMed ID: 29748203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation parameters between intra-voxel incoherent motion and diffusion-weighted imaging in grading and differentiating histological subtypes of meningioma: A prospective pilot study.
    Yiping L; Kawai S; Jianbo W; Li L; Daoying G; Bo Y
    J Neurol Sci; 2017 Jan; 372():60-69. PubMed ID: 28017250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
    Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
    Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping.
    Zhang S; Chiang GC; Knapp JM; Zecca CM; He D; Ramakrishna R; Magge RS; Pisapia DJ; Fine HA; Tsiouris AJ; Zhao Y; Heier LA; Wang Y; Kovanlikaya I
    J Neuroradiol; 2020 Jun; 47(4):272-277. PubMed ID: 31136748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of three-dimensional pseudo-continuous arterial spin labelling in grading and differentiating histological subgroups of meningiomas.
    Lu Y; Xiong J; Yin B; Wen J; Liu L; Geng D
    Clin Radiol; 2018 Feb; 73(2):176-184. PubMed ID: 29031810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
    Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
    World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 and ADC histogram parameters may be an in vivo biomarker for predicting the grade, subtype, and proliferative activity of meningioma.
    Cao T; Jiang R; Zheng L; Zhang R; Chen X; Wang Z; Jiang P; Chen Y; Zhong T; Chen H; Wu P; Xue Y; Lin L
    Eur Radiol; 2023 Jan; 33(1):258-269. PubMed ID: 35953734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
    Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
    Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
    J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral Brain Edema in Meningiomas Depends on Aquaporin-4 Expression and Not on Tumor Grade, Tumor Volume, Cell Count, or Ki-67 Labeling Index.
    Gawlitza M; Fiedler E; Schob S; Hoffmann KT; Surov A
    Mol Imaging Biol; 2017 Apr; 19(2):298-304. PubMed ID: 27552812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.